Sustainability Report

Overview

The report is Duopharma Biotech's fourth Sustainability Report and covers its Malaysian operations for 1 January-31 December 2018 after the 2017 demerger. It describes the company's first materiality assessment, which identified 20 material matters, and a formal sustainability governance framework in which the Board is accountable and the Risk Management and Sustainability Committee supervises implementation. The report also highlights improved 2018 safety performance, with total recordable incidents falling from seven to five and TRCF declining from 1.85 to 1.14.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2018
Period: 1 January 2018 – 31 December 2018
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services